S. Korea to approve use of AstraZeneca Covid-19 vaccine for all aged 18-plus
A man holds an ampule of the Oxford-AstraZeneca’s Covishield vaccine at the Dhaka Medical College vaccination center in Dhaka, Bangladesh, on February 9, 2021. REUTERS
SEOUL — South Korea’s drug safety ministry on Wednesday said it will approve the use of AstraZeneca’s Covid-19 vaccine for all people, including those aged 65 and over.
The AstraZeneca shot, co-developed by Britain’s Oxford University, is the first vaccine to be granted approval in the country.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
